These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 25129671)
21. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial. Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449 [TBL] [Abstract][Full Text] [Related]
22. Coronary bifurcation treated with the hybrid mini-crush approach: a potential application of three-dimensional optical coherence tomography to optimise stent apposition. Soltani F; Daghem S; Farooq V; El-Omar M EuroIntervention; 2015 Dec; 11(8):e1. PubMed ID: 26696317 [No Abstract] [Full Text] [Related]
23. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry. Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477 [TBL] [Abstract][Full Text] [Related]
25. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study. Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463 [TBL] [Abstract][Full Text] [Related]
26. Usefulness of rotational atherectomy in preventing polymer damage of everolimus-eluting stent in calcified coronary artery. Kuriyama N; Kobayashi Y; Yamaguchi M; Shibata Y JACC Cardiovasc Interv; 2011 May; 4(5):588-9. PubMed ID: 21596335 [No Abstract] [Full Text] [Related]
27. Treating the left main bifurcation lesion: the "three stent solution". Uretsky BF Catheter Cardiovasc Interv; 2009 Jan; 73(1):42-3. PubMed ID: 19089935 [No Abstract] [Full Text] [Related]
28. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
29. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057 [TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265 [TBL] [Abstract][Full Text] [Related]
31. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing. Džavík V; Colombo A JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424 [TBL] [Abstract][Full Text] [Related]
32. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532 [TBL] [Abstract][Full Text] [Related]